Table 2.
Descriptive data of the control group and patients with congenital heart disease.
| Control group |
CHD |
p | Subgroup analysis | Simple lesions |
Complex lesions (n = 36) | p | ||
|---|---|---|---|---|---|---|---|---|
| (n = 42) | (n = 75) | (n = 39) | ||||||
| Sex female | n (%) | 16 (38.1) | 29 (38.7) | 0.95a | 15 (38.5) | 14 (38.9) | 0.97b | |
| Age years | mean ± SD | 36.9 ± 14.9 | 37.5 ± 15.5 | 0.83a | 35.0 ± 13.9 | 40.3 ± 16.9 | 0.14b | |
| Height m | mean ± SD | 1.76 ± 0.09 | 1.73 ± 0.09 | 0.14a | 1.73 ± 09 | 1.73 ± 0.1 | 0.65b | |
| Weight kg | mean ± SD | 79.5 ± 16.5 | 73.2 ± 15.5 | 0.04a,⁎ | 0.35c | 76.1 ± 16.4 | 70.2 ± 14.1 | 0.10b |
| 0.01d,⁎⁎ | ||||||||
| BMI kg/m2 | mean ± SD | 25.8 ± 5.3 | 24.4 ± 4.3 | 0.12a | 25.1 ± 4.4 | 23.5 ± 4.1 | 0.10b | |
| Smoking | ||||||||
| Non-smoker | n (%) | 37 (88.1) | 63 (84.0) | 0.6a | 30 (76.9) | 33 (91.7) | 0.15b | |
| Active smoker | 4 (9.5) | 7 (9.3) | 6 (15.4) | 1 (2.8) | ||||
| Previous smoker | 1 (2.4) | 5 (6.7) | 3 (7.7) | 2 (5.6) | ||||
| Cardiovascular medication yes | n (%) | 8 (19.0) | 37 (49.3) | 0.001a,⁎⁎⁎ | 0.22c | 12 (30.8) | 25 (69.4) | 0.001b,⁎⁎⁎ |
| <0.001d,⁎⁎⁎ | ||||||||
| SBP mmHg | mean ± SD | na | 128 ± 21 | na | 134 ± 21 | 123 ± 20 | 0.03b,⁎ | |
| DBP mmHg | mean ± SD | na | 75 ± 11 | na | 75 ± 11 | 75 ± 10 | 0.45b | |
| NYHA class | ||||||||
| I | n (%) | na | 53 (70.7) | na | 38 (97.4) | 15 (41.7) | <0.001b,⁎⁎⁎ | |
| II | 12 (16.0) | 1 (2.6) | 11 (30.6) | |||||
| III | 10 (13.3) | 0 (0) | 10 (27.8) | |||||
| IV | 0 (0) | 0 (0) | 0 (0) | |||||
| Previous intervention yes | n (%) | na | 41 (54.7) | na | 16 (41.0) | 25 (69.4) | 0.01b,⁎⁎ | |
| Age at intervention years | median (IQR) | na | 5.0 (3.0–18.0) | na | 12.0 (4.0–25.5) | 4.5 (2.0–11.0) | 0.22b | |
| Previous interventions number of | median (IQR) | na | 1 (0–2) | na | 0 (0–1) | 1 (0–3) | 0.001b,⁎⁎⁎ | |
| Device | ||||||||
| PM | n (%) | na | 2 (2.7) | na | 1 (2.6) | 1 (2.8) | 0.33b | |
| ICD | na | 2 (2.7) | 0 (0) | 2 (5.6) | ||||
| Reaching recommended PAL (IPAQ) yes | n (%) | 32 (76.2) | 53 (70.7) | 0.52a | 30 (76.9) | 23 (63.9) | 0.22b | |
| Reaching recommended PAL (Actiheart) yes | n (%) | 24 (57.1) | 36 (48.0) | 0.34a | 21 (53.8) | 15 (41.7) | 0.29b |
CHD, congenital heart disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; NYHA, New York Heart Association; PM, pacemaker; ICD, implantable cardioverter defibrillator; IPAQ, international physical activity questionnaire. a) Comparison between control group and CHD. b) Comparison between patients with simple and complex lesions. c) Comparison between control group and patients with simple lesions. d) Comparison between control group and patients with complex lesions. Bold text indicates significant levels.
⁎
p < 0.05.
⁎⁎
p < 0.01.
⁎⁎⁎
p ≤ 0.001.